What is Rituximab?

Category: Prescription Drugs

Most popular types: Rituxan Mabthera

false

See also: DRC protocol FCMR protocol ILD Phase II/III Rituximab Versus Cyclophosphamide RECITAL Study R-CVP protocol RT protocol

Rituximab is a medication in a class of medications called monoclonal antibodies and given by infusion. It is used in the treatment of non-Hodgkins lymphoma and also in the treatment of rheumatoid arthritis.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Multiple sclerosis 111 77
Rheumatoid arthritis 89 46
Neuromyelitis optica 58 35
Systemic lupus erythematosus 20 9
Chronic lymphocytic leukemia 17 9
Follicular lymphoma 13 8

Show all 88 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 33
Moderate 37
Mild 73
None 84

Commonly reported side effects and conditions associated with Rituximab

Side effect Patients
Fatigue 29
Nausea 21
Headaches 10
Allergic reaction 7
Flu like symptoms 6
Hair loss 5

Show all 128 reported side effects

Dosages

Based on patients currently taking Rituximab

Dosage Patients
10 mg every 6 months 16
1,000 mg every 6 months 5
10 mg every 12 weeks 3
10mg/mL as needed 3
500 mg every 6 months 3
10 mg yearly 2
10 mg every 3 months 2
10 mg weekly 2
100 mg every 6 months 2
1 other every 6 months 2

See all 37 dosages

Why patients stopped taking Rituximab

Multiple reasons could be selected

Reason Patients
Course of treatment ended 56
Did not seem to work 39
Doctor's advice 30
Side effects too severe 26
Other 18
Change in health plan coverage 5
Expense 4
Personal research 3
See all 153 patients who've stopped taking Rituximab

Duration

Currently taking Rituximab

Duration Patients
1 - 6 months 2
6 months - 1 year 6
1 - 2 years 17
2 - 5 years 32
5 - 10 years 9
10 years or more 7

Stopped taking Rituximab

Duration Patients
Less than 1 month 62
1 - 6 months 31
6 months - 1 year 19
1 - 2 years 16
2 - 5 years 22
5 - 10 years 2
10 years or more 1
Adherence
Adherence Evaluations
Always 200
Usually 8
Sometimes 5
Never taken as prescribed 14
Burden
Burden Evaluations
Very hard to take 20
Somewhat hard to take 67
A little hard to take 73
Not at all hard to take 67
Cost per month
Cost per month Evaluations
$200+ 34
$100-199 12
$50-99 5
$25-49 6
< $25 66
Not specified 104

What people switch to and from

Patients started taking Rituximab after stopping:

Treatment Patients
Natalizumab (Tysabri) 16
Glatiramer acetate (Copaxone) 8
Methotrexate (Apo-Methotrexate) 8
Dimethyl fumarate (Tecfidera) 7
Fingolimod (Gilenya) 7

Show all 31 treatments patients report switching from

Patients stopped taking Rituximab and switched to:

Treatment Patients
Tocilizumab (Actemra) 5
Natalizumab (Tysabri) 4
Ibrutinib (Imbruvica) 3
Dimethyl fumarate (Tecfidera) 2
Methotrexate (Apo-Methotrexate) 2

Show all 20 treatments patients report switching to

Last updated:

19 patient evaluations for Rituximab

May 18, 2018 (Started Jan 15, 2016)

  • Effectiveness
    Slight (for non-Hodgkin's lymphoma)
  • Effectiveness
    Slight (for follicular lymphoma)
  • Side effects
    Mild (fatigue)
  • Adherence
    Never taken as prescribed
  • Burden
    Somewhat hard to take
Advice & Tips: Discontinued December 2016 because treatment was no longer having any effect on my lymphoma
Cost: < $25 monthly

Jan 29, 2017 (Started Jan 15, 2016)

  • Effectiveness
    Moderate (for non-Hodgkin's lymphoma)
  • Effectiveness
    Moderate (for follicular lymphoma)
  • Side effects
    Moderate (fatigue)
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Cost: < $25 monthly

Dec 15, 2016 (Started Jan 15, 2016)

  • Effectiveness
    Slight (for non-Hodgkin's lymphoma)
  • Effectiveness
    Slight (for follicular lymphoma)
  • Side effects
    Moderate (fatigue)
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 10 mg Weekly
Cost: < $25 monthly

  • 0 helpful marks

Feb 15, 2017 (Started Jul 15, 2016)

  • Effectiveness
    Moderate (for multiple sclerosis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: As needed

  • 1 helpful mark

Sep 24, 2016 (Started Sep 11, 2014)

  • Effectiveness
    Slight (for rheumatoid arthritis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: As needed
Advice & Tips: I had 2 infusions, 14 days apart. And that was it. The effect was not worth the price according to my rheumatologist (I paid nothing myself)
Cost: < $25 monthly

Jul 1, 2014 (Started Sep 11, 2014)

  • Effectiveness
    Slight (for rheumatoid arthritis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Cost: < $25 monthly

  • 0 helpful marks
Last updated:
Showing 3 of 19 patient evaluations for Rituximab